Marcin Sawicki

Learn More
The aim of this paper is to discuss brachytherapy treatment and individual applicators suitable for unfavorably localized superficial malignant lesions. Techniques for manufacturing an individual applicator and clinical examples of its use for various locations of cancer are presented. This techniques are based on individual size and shape of the tumour.(More)
OBJECTIVE To investigate whether assessment of C-reactive protein (CRP) and apolipoproteins, besides the traditional lipid profile, enhances the assessment process for the risk of acute coronary syndrome (ACS). METHODS The study group consisted of 220 consecutive patients admitted to hospital within the first 6 hours from the onset of chest pain. Patients(More)
PURPOSE Endobronchial brachytherapy (EB) is one way of treatment of patients with advanced lung cancer. Technological progress and the introduction of computed tomography for use in 3D planning allows one to define the area being treated very precisely, which gives an opportunity to extend survival, even in groups of patients receiving palliative care. (More)
PURPOSE To present comparison of treatment plans made by using 2D and 3D methods in the planning system, as well as to assess the quality of treatment plans using the 2D and 3D methods. MATERIAL AND METHODS The studies involved a group of 31 patients with advanced lung cancer treated in the Brachytherapy Department of the Subcarpathian Cancer Center in(More)
BACKGROUND Acute coronary syndromes (ACS) are the leading cause of hospitalization and death in the modern world. Reliable indicators of risk assessment could be useful in clinical investigation. Results from recent studies suggest that apolipoprotein measurement and apoB:apoI ratio are superior to traditional lipids in the estimation of coronary risk. We(More)
INTRODUCTION Diagnosis of acute coronary syndrome (ACS) is frequently a challenging task while immediate risk stratification remains crucial for the prompt implementation of appropriate therapy in this setting. The prolonged release pattern of both CK-MB mass and cardiac troponins makes it difficult to identify the origin of recent chest pain, thus a(More)
  • 1